2 results
Approved WMORecruiting
To assess the safety and efficacy of the FANTOM ENCORE sirolimus-eluting BRS.
Approved WMORecruiting
To evaluate the efficacy of PTC857 in reducing disease progression in subjects with amyotrophic lateral sclerosis (ALS)